Anjie Zhen, PhD

Dr. Zhen's primary research interests are on gene therapy and engineered immunity to treat HIV infection, cancer and other chronic diseases. Her group studies hematopoietic stem cell based chimeric antigen receptor (CAR) therapy and mechanisms of immune exhaustion. They are also actively investigating how substance abuse, particularly cannabis, alter innate and adaptive immune responses in the context of HIV infection and cancer.